Operating Lease, Right-of-Use Asset of Neumora Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neumora Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Neumora Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $474,000, a 82% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Neumora Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $474,000 -$2,158,000 -82% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $531,000 -$2,934,000 -85% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $900,000 -$3,376,000 -79% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,777,000 -$3,291,000 -65% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $2,632,000 -$3,322,000 -56% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $3,465,000 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $4,276,000 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $5,068,000 -$3,163,000 -38% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $5,954,000 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q4 2022 $8,231,000 31 Dec 2022 10-K 07 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.